Newly published clinical study on SkinAx² confirms its capacity to improve skin radiance by oral route
SkinAx², a patented anti-aging formula developed by French company Activ’Inside, has been backed by a clinical study on its capacity to improve skin radiance by oral route. The study has just been published in Clinical, Cosmetic and Investigational Dermatology.
SkinAx² ingredients have been carefully selected for their demonstrated and complementary beneficial effects on skin, already reported in more than 40 scientific publications. Combining French grape (Vitis vinifera L.) and melon (Cucumis melo L.) extracts rich in polyphenols and SuperOxide Dismutase (SOD), zinc and vitamin C, SkinAx² provides both primary and secondary antioxidants for an optimal and synergistic protection against skin oxidation.
Clinically tested under dermatological control on 35 women using both subjective and objective methods, SkinAx² was found to improve all the parameters involved in skin radiance (colour, contrast, imperfection). After two months of oral supplementation (150mg of SkinAx²/day), 82% of women enrolled had a more even complexion and a brighter skin.
'Contrary to most skin anti-aging solutions, SkinAx² not only acts on a single parameter but has a full and complementary action on all factors involved in skin radiance: your skin is more luminous, smoother and firmer, with fewer imperfections,' said Marion Dumoulin, co-author of the study. 'Overall, more than 20 clinical results detailing the SkinAx² efficacy have been obtained, each representing one validated differentiating message for the final consumers.'
Available both as an ingredient or a ready-to-use formulation for private labelling, SkinAx² was selected as one of the three finalists of the NutraIngredients awards organised during the last Vitafoods Europe show; it has also been chosen as a finalist in CPG Editor’s Choice Award, the winner of which will be selected at the forthcoming Supply Side West event.